He presented on “Fibril Generation in Amyloidosis: Potential for Therapeutic Interruption.” In the session he discussed new opportunities for therapeutically preventing, interrupting and reversing amyloid deposition in the kidney and other organs.
Other members of the research team responsible for the findings included Jiamin Teng, M.D., Ph.D., associate professor of pathology; Elba Turbat-Herrera, M.D., professor of pathology; Luis del Pozo-Yauner, M.D., Ph.D., assistant professor of pathology; and Chun Zeng, Ph.D., research associate in pathology.
Herrera earned his medical degree from the University of Puerto Rico School of Medicine in San Juan. He completed his residency training in anatomic and clinical pathology at Brooke Army Medical Center in San Antonio, Texas. He is certified by the American Board of Pathology in anatomic and clinical pathology and cytopathology.
